US EditionPublished • loading... • Updated
Nestlé joins microbiome therapeutics group
Summary by CDR – Chain Drug Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Nestlé joins microbiome therapeutics group
BRIDGEWATER, N.J. — Nestlé Health Science has joined the Microbiome Therapeutics Innovation Group (MTIG), aligning the company with a growing industry effort to advance regulatory clarity and commercial pathways for microbiome-based therapies.The coalition, which brings together companies developing FDA-approved microbiome therapeutics, focuses on improving the regulatory, investment, and market environment to accelerate innovation and patient a…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
